Tachyon Therapeutics
Tachyon is advancing novel first-in-class compounds against significant new drug targets for treatments against cancer.
Tachyon is advancing novel first-in-class compounds against significant new drug targets for treatments against cancer.
Tachyon is accelerating innovative science to develop first-in-class therapeutics against significant new drug targets in cancer biology. Tachyon operates with a dedicated internal core development team and a world-class external network of expertise to achieve one goal - advance our programs with speed, innovation, quality and scientific integrity.
There is no investment information
No recent news or press coverage available for Tachyon Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
